Rick Pauls
President and Chief Executive Officer
Replay available
DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Julie Krop
Chief Medical Officer
Scott Kellen
Chief Financial Officer
Josh Shimmer
Analyst, Cantor Fitzgerald
Stacy Koo
Analyst, TD Cowen
Thomas Flavin
Analyst, Lake Street
Matthew Caulfield
Analyst, H.C. Wainwright
Jay Kahn
Analyst, Craig-Hallam (for Chase Knickerbocker)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Diamedica Therapeutics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.115 Good morning, ladies and gentlemen, and welcome to the Diametica Therapeutics 00:00:05.115 -- 00:00:09.238 second quarter 2026 earnings conference call. 00:00:09.238 -- 00:00:14.581 An audio recording of this webcast will be available shortly after the call today 00:00:14.581 -- 00:00:19.463 on Diametica's website at www.diametica.com 00:00:21.686 -- 00:00:27.088 in the investor relations section. Before the company proceeds with its remarks, 00:00:27.088 -- 00:00:33.170 Please note that the company will be making forward-looking statements on today's call. 00:00:33.170 -- 00:00:38.552 These statements are subject to risks and uncertainties that could cause actual 00:00:38.552 -- 00:00:43.934 results to differ materially from those projected in these statements. 00:00:43.934 -- 00:00:49.296 More information, including factors that could cause actual results to differ 00:00:49.296 -- 00:00:54.772 from projected results, appear in the section entitled Cautionary Statements 00:00:54.772 -- 00:00:59.974 Note regarding forward-looking statements in the company's press release issued 00:00:59.974 -- 00:01:05.157 yesterday and under the heading Risk Factors in Diametica's 00:01:05.157 -- 00:01:10.559 most recent annual report on Form 10-K and most recent 00:01:10.559 -- 00:01:15.682 quarterly report on Form 10-Q. Diametica's SEC 00:01:15.682 -- 00:01:20.503 filings are available at www.sec.gov 00:01:22.905 -- 00:01:28.189 and on its website. Diomedica's President and Chief Executive 00:01:28.189 -- 00:01:31.510 Officer, Mr. Pauls. You may begin. 00:01:56.472 -- 00:01:59.274 Thank you, Morgan, and thank you all for joining us today. 00:01:59.274 -- 00:02:03.858 With me this morning are Dr. Julie Krop, our Chief Medical Officer, and Scott K...